Markets › India › NSE › MANKIND

Mankind Pharma Ltd

NSE:MANKINDHealthcareNSE:CNX200NSE:CNX500

₹2,253.20−0.98%At closeAt close · Mon 19 Oct · ≈ AED 86.93 · Market cap $9.87B · Next earnings Mon 26 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	70.6%	68.3%	66.1%	68.3%	70.8%	43.1%	—	—
Operating margin	25.9%	24.2%	18.8%	21.8%	20.6%	19.1%	19.1%	+0.0 pts
Net margin	20.4%	18.4%	14.7%	18.6%	16.3%	13.4%	13.4%	+0.0 pts
EBITDA margin	29.4%	28.2%	23.3%	27.3%	29.1%	27.0%	—	—
Return on equity	26.8%	23.3%	17.2%	20.4%	13.9%	11.7%	11.6%	−0.2 pts
Return on assets	19.9%	15.7%	13.2%	16.0%	7.2%	6.8%	6.8%	+0.0 pts
Return on capital employed	32.0%	28.9%	20.9%	22.7%	11.4%	12.7%	—	—
Debt / equity	0.1×	0.1×	0.0×	0.0×	0.6×	0.4×	0.4×	−1.6%
Debt / assets	3.8%	9.5%	1.8%	1.7%	30.7%	22.5%	—	—
Interest coverage	90.7×	93.1×	39.1×	80.5×	6.2×	4.3×	—	—
Current ratio	2.9×	1.7×	2.3×	3.1×	1.2×	1.1×	1.1×	+0.0%
Quick ratio	2.0×	1.0×	1.5×	2.4×	0.9×	0.7×	—	—
Cash ratio	0.1×	0.1×	0.2×	0.2×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	1.0×	0.9×	0.9×	0.9×	0.4×	0.5×	—	—
Inventory turnover	1.5×	1.4×	2.0×	2.1×	1.7×	3.8×	—	—
Receivables turnover	14.6×	18.2×	14.4×	12.1×	7.9×	8.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	2.2%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.